Ivosidenib
Ivosidenib | |
---|---|
Term | Ivosidenib |
Short definition | ivosidenib (I-voh-SIH-deh-nib) A medicine used alone or with other medicines to treat adults with certain types of acute myeloid leukemia or cholangiocarcinoma (a type of bile duct cancer ) that have a mutation (change) in the bile duct IDH1 gene. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
ivosidenib - (pronounced) (I-voh-SIH-deh-nib) A medicine used alone or with other medicines to treat adults with certain types of acute myeloid leukemia or cholangiocarcinoma (a type of bile duct cancer ) that have a mutation (change) in the bile duct IDH1 gene. It is also being studied in the treatment of other types of cancer. Ivosidenib blocks the protein IDH1 gene made by the mutant, which can help stop cancer cells from growing. It's kind of an enzyme inhibitor and kind of targeted therapy. Also called Tibsovo
External links
- Medical encyclopedia article on Ivosidenib
- Wikipedia's article - Ivosidenib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski